Latest stories on PRME
PRME begins first-in-human PM577a study as first Wilson disease patient is dosed
MarketChameleon63 · neutralproduct/pr
Prime Medicine stock rating maintained at Market Outperform by Citizens
Investing.com Analyst Ratings61 · neutralanalyst
Prime Medicine doses first patient in PM577a trial
The Fly56 · neutralproduct/pr
Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
Business Insider63 · neutralproduct/pr
Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease
GlobeNewswire63 · neutralproduct/pr
Citizens reiterates Prime Medicine stock rating on gene editing capabilities
Investing.com Analyst Ratings56 · neutralanalyst
Prime: A Buy Due To BLA Filing H1 '27 And Continued PM647 Advancement
Seeking Alpha63 · neutralproduct/pr
At a glance: stocks gapping up premarket
Seeking Alpha63 · neutralgeneral
Prime Medicine stock holds at outperform on FDA IND clearance
Investing.com Analyst Ratings63 · neutralproduct/pr
Prime Medicine stock jumps 8% after FDA clears PM647 trial
Seeking Alpha67 · bullishproduct/pr
Stocks to Watch: Akamai, Scholastic, Prime Medicine
MarketWatch50 · neutralgeneral
Prime Medicine Shares Jump on FDA Clearance for Investigational New Drug Application
Morningstar73 · bullishproduct/pr
Prime Medicine Shares Jump on FDA Clearance for Investigational New Drug Application
MarketWatch73 · bullishproduct/pr
Why is Prime Medicine stock surging today?
Investing.com Markets50 · neutralgeneral
Prime Medicine stock surges on FDA IND clearance
Investing.com Markets73 · bullishproduct/pr
Prime Medicine announces FDA clearance of IND application for PM647
The Fly67 · bullishproduct/pr
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency
GlobeNewswire67 · bullishproduct/pr
CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks?
Stocktwits News38 · neutralgeneral
Prime Medicine, Inc. (PRME) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Prime Medicine to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Prime Medicine to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Prime Medicine transferred with Buy rating at Chardan
The Fly61 · neutralanalyst
BMO initiates Prime Medicine stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
BMO starts Prime Medicine at Outperform into 2027 readouts
The Fly61 · neutralanalyst
Prime Medicine initiated with an Outperform at BMO Capital
The Fly61 · neutralanalyst